Library

APICA

APICA (also known as SDB-001, and 2NE1) is a novel synthetic cannabinoid that produces modified cannabis-like effects when administered. It has been shown to act as a potent agonist for the CB1 and CB2 cannabinoid receptors.

APICA molecular structure
APICA molecular structure diagram from the DrugsPRO substance library.

Also known as: SDB-001, 2NE1

Classification

  • Chemical: Cannabinoid
  • Chemical: Synthetic cannabinoid
  • Tag: Indole cannabinoid
  • Tag: Indolecarboxamide

Effects

  • Spontaneous Bodily Sensations
  • Vasodilation
  • Pain Relief
  • Dry Mouth
  • Sedation
  • Thought Connectivity
  • Mindfulness
  • Conceptual Thinking
  • Anxiety
  • Paranoia
  • Thought Deceleration
  • Auditory Distortion
  • Dehydration
  • Changes In Felt Gravity
  • Perception Of Bodily Heaviness
  • Increased Music Appreciation
  • Auditory Acuity Enhancement

Routes of Administration

Smoked

Dosage

  • Threshold: 0.5 mg
  • Heavy: 4 mg
  • Common: 1.5-2 mg
  • Light: 0.5-1.5 mg
  • Strong: 2-4 mg

Duration

  • Onset: 0 h
  • Peak: 0.2-0.5 h
  • Offset: 0.1-0.2 h
  • After Effects: 0.2-0.6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

APICA - DrugsPRO substansvejledning

APICA: APICA (also known as SDB-001, and 2NE1) is a novel synthetic cannabinoid that produces modified cannabis-like effects when administered. It has been shown to act as a potent agonist for the CB1 and CB2 cannabinoid receptors.

Related pages